The utility of pharmacogenetic testing to support the treatment of bipolar disorder

Marta Ielmini,1 Nicola Poloni,1 Ivano Caselli,1 Jordi Espadaler,2 Miquel Tuson,2 Alessandro Grecchi,3 Camilla Callegari1 1Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy; 2AB-BIOTICS S.A, R&D Unit, Sant Cugat del Valles, Barcelona, Spain; 3AS...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ielmini M, Poloni N, Caselli I, Espadaler J, Tuson M, Grecchi A, Callegari C
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2018-03-01
Collection:Pharmacogenomics and Personalized Medicine
Sujets:
Pharmacogenetics testing
bipolar disorder
personalized medicine
pharmacogenetics
adverse events
Accès en ligne:https://www.dovepress.com/the-utility-of-pharmacogenetic-testing-to-support-the-treatment-of-bip-peer-reviewed-article-PGPM
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires